The Nashua, NH-based firm sold an aggregate of approximately 1.2 million shares of its common stock, along with five-year warrants to purchase about 584,000 shares to three institutional and accredited investors for a total price of $5.25 million. In addition, iCAD has received commitments from an additional limited number of institutional and accredited investors for up to $3.175 million of additional equity financing.
iCAD said it expects to use approximately $3.3 million of the proceeds to reduce its borrowings under a line of credit with the company's chairman, and an additional $625,000 to reduce accrued interest and related obligations.
By AuntMinnie.com staff writers
December 16, 2004
Viatronix, iCAD sign licensing deal, November 30, 2004
Hologic, iCAD ink development deal, November 23, 2004
Road to RSNA, iCAD, November 10, 2004
FDA OKs use of Second Look CAD with Selenia, September 13, 2004
Copyright © 2004 AuntMinnie.com